Back to Cresset Asset Management, LLC Cresset Asset Management, LLC

NVONVO

Showing 8 of 31 quarters

Position history for Cresset Asset Management, LLCCresset Asset Management, LLC's holdings in Novo Nordisk A/S

Yes. Cresset Asset Management holds 30,890 shares of NVO (Novo Nordisk), worth $1.5M, as of its Q2 2026 13F filing. It reduced the position by 931 shares (-2.9%) from Q1 2026. Cresset Asset Management has held NVO in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$1.5M

Current Shares

30,890

Total Value Change

-$15.5M

Total Shares Change

-111,720

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
30,890
-2.9%
$1.5M0.0%$47.34
0
2026-Q1
Decreased
31,821
-6.2%
$1.2M0.0%$36.29
0
2025-Q4
Increased
33,936
+5.0%
$1.7M0.0%$48.46
27
2025-Q3
Increased
32,314
+4.0%
$1.8M0.0%$52.85
27
2025-Q2
Decreased
31,081
-48.3%
$2.1M0.0%$65.01
0
2025-Q1
Increased
60,066
+5.7%
$4.2M0.0%$65.40
28
2024-Q4
Decreased
56,836
-60.1%
$4.9M0.0%$79.73
0
2024-Q3
Decreased
142,610
-0.1%
$17M0.1%$110.37
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used